RD03/2016

· NTC srl

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RD03/2016, covering 2024-09-27 to 2024-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults [Phase 2]

See pricing